Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Services
Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks
Mendeley

Cite by
Google Scholar
PMC(1)


Article History
Submitted: 03 Dec 2014
Revised: 14 Apr 2015
First published online: 19 Sep 2015

Article Access Statistics
Abstract Page Views: 278
PDF Downloads: 145
Full Text Views: 0

Adv Pharm Bull. 2015;5(3):393-401 doi: 10.15171/apb.2015.054
PMID:26504762        PMCID:PMC4616886

Efficient Inactivation of Multi-Antibiotics Resistant Nosocomial Enterococci by Purified Hiracin Bacteriocin

Original Research

Maryam Hassan 1 * , Dag Anders Brede 2, Dzung B. Bao Diep 2, Ingolf F. f Nes 2, Farzaneh Lotfipour 3, Zoya Hojabri 4

1 Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
2 Norwegian University of Life Sciences, Department of Chemistry, Biotechnology and Food Science, Laboratory of Microbial Gene Technology, N1432 Aas, Norway.
3 Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
4 Department of Microbiology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.



Abstract

Purpose: Because of the emergence of multi-antibiotic resistant bacteria, a number of infectious diseases have become a major concern to treat in health care services worldwide. This situation is worsened by the fact that very limited progress has been made in developing new and potent antibiotics in recent years. In this context antimicrobial peptides (AMPs) represent new potential therapeutic compounds with bactericidal or bacteriostatic activity against closely related bacterial strains.

Methods: In this study, a collection of enterococci (n=170) from clinical sources were investigated for their potential to inhibit multiresistant nosocomial enterococci from Iranian hospitals.

Results: Four isolates produced antimicrobial peptides that inhibited all the antibiotic resistant enterococci. This included three Enterococcus faecium isolates producing combinations of enterocin A, B and L50 AB. The most potent antagonism was produced by E. faecalis HO91. Purification and subsequent characterization by MALDI-TOF MS, Edman degradation and DNA-sequencing revealed that the antimicrobial compound was Hiracin. The purified Hiracin was evaluated for antibacterial activity against 12 multiresistant enterococcal isolates from clinical samples. The results demonstrated that Hiracin is highly effective towards enterococci which were resistant even to antibiotics from four distinct classes.

Conclusion: The present research addresses Hiracin as a promising alternative to conventional antibiotics in treatment of multiresistant enterococcal infections.







Comments
First name  
Last name  
Email address  
Comments  
Security code



This Article
PDF

Google Scholar
Articles by Hassan M
Articles by Brede DA
Articles by Diep DBB
Articles by Nes IFF
Articles by Lotfipour F
Articles by Hojabri Z

PubMed
Articles by Hassan M
Articles by Brede DA
Articles by Diep DBB
Articles by Nes IFF
Articles by Lotfipour F
Articles by Hojabri Z

Similar articles in PubMed

Share this article!

Press Manuscript Online. Powered by MAADRAYAN